Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
Condition(s):Breast CancerLast Updated:July 20, 2021Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:July 20, 2021Not yet recruiting
Condition(s):HealthyLast Updated:April 29, 2008Completed
Condition(s):ContraceptionLast Updated:December 2, 2014Completed
Condition(s):SchizophreniaLast Updated:July 2, 2019Terminated
Condition(s):Intrauterine AdhesionLast Updated:November 20, 2017Unknown status
Condition(s):Pulmonary Arterial HypertensionLast Updated:December 9, 2019Completed
Condition(s):Urinary Tract InfectionsLast Updated:February 4, 2022Terminated
Condition(s):Breast CancerLast Updated:June 5, 2023Recruiting
Condition(s):Metastatic Breast CancerLast Updated:September 16, 2014Completed
Condition(s):Hemorrhagic ShockLast Updated:March 19, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.